Xentria, Inc.
PrivateLast Round
Growth Equity
Oct 18, 2022
Total Funding Raised
$25M
Company Overview
Xentria, Inc. operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Growth Equity round in October 2022.
Xentria, Inc. is a biopharmaceutical company that develops novel biologics and biosimilars for rare diseases, immunologic disorders, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xentria, Inc. Comparables
Compare Xentria, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SarcoMed USA | 81% | |
| Roivant Sciences | 78% | |
| aTyr Pharma | 77% |
For institutional investors. Book with your work email.
Xentria, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 18, 2022
$25M raised in growth equity round.
For institutional investors. Book with your work email.
Xentria, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xentria, Inc.'s valuation, stock price, and market status.
Is Xentria, Inc. a public or private company?
Xentria, Inc. is a private company.
What is the current stock price of Xentria, Inc.?
Xentria, Inc. is a private company, so its shares have no public market price. Caplight tracks Xentria, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xentria, Inc. worth (valuation)?
Valuation information for Xentria, Inc. is not publicly available.
Can I buy Xentria, Inc. stock?
Xentria, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xentria, Inc.'s last funding round?
Xentria, Inc.'s most recent funding round was Growth Equity on October 18, 2022.
Who are the main investors in Xentria, Inc.?
Investor information for Xentria, Inc. is not publicly disclosed.
Will Xentria, Inc. IPO soon?
No public IPO plans have been announced for Xentria, Inc..
How can I track Xentria, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Xentria, Inc.'s shares on secondary markets.